• Skip to content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer

Trading With Cody

Long-term Revolution Investments and Real-time Trades from Cody Willard


  • Twitter

  • YouTube

  • iTunes Podcasts

  • SoundCloud
  • Trade Alerts
  • Latest Positions
  • All Archives
  • Chat Room
  • Books
  • About/FAQ/More Info
    • The Cody Willard Show
    • Testimonials
    • FAQ
    • Contact
    • Privacy Policy
    • Support
    • Money management services
    • Public Speaking
    • Login

GW Pharma spikes

March 14, 2016 by Cody Willard

Well, we covered about 1/3 of our GWPH short a month ago to lock in a 50% gain, as the stock had been more than cut in half since we shorted it. This morning, GW Pharma announced the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex (cannabidiol or CBD) for the treatment of Dravet syndrome.

I don’t think that GW Pharma can make a sustainable, patent-protected product cycle for any of their cannabis-derived products, but the headlines alone today are enough to wipe out our remaining gains in this stock as it pops back to where it was when we first shorted it. I can tell you that we’ve been researching the potential for cannabidoil to help our own little daughter with some seizures she had early on but that seem to have subsided on their own lately. I don’t think these products will have the type of margins that we see at Gilead or other big biotech drug companies that are fleecing the US taxpayer to the tune of 90% gross margins and which GW Pharma investors expect to see.

None of that will matter this morning as the stock goes crazy. I’m in no rush to make any new moves in this name and will likely let it trade itself out today and tomorrow.

I’ll be back with additional markets, economic and stock analysis later.

 

  • Twitter
  • YouTube
  • iTunes Podcasts
  • SoundCloud

Related posts:

I've got a new name I'll be pulling the trigger on tomorrow...
In depth analysis on this market and economy
TWC App, Chat and Fed analysis
Huge day for theTradingWithCody portfoli...
Here’s a list of my positions, including our latest purchase from this week...

Filed Under: Trading

Disclosure: At the time of publication, the firm in which Willard is a partner and/or Mr. Willard had positions in some of the stocks mentioned above although positions can change at any time and without notice.

Reader Interactions

Primary Sidebar

You are not currently logged in.








» Register
» Lost your Password?

Subscribe now. You can cancel at anytime.

Footer

Disclosure: The firm in which Willard is a partner and/or Mr. Willard has positions in some of the stocks mentioned on this site although positions can change at any time and without notice.

Copyright © 2021 · Magazine Pro on Genesis Framework · WordPress · Log in